Место корректирующих растворов метаболического действия в инфузионной терапии и требования к ним кардиологической практики (обзор литературы)

1. Cosnett JE. The origins of intravenous fluid therapy. Lancet 1989;
768–71.
2. Latta T. Relative to the treatment of cholera by the copious injection of
aqueous and saline fluids into the veins. Lancet 1831; 2: 274–7.
3. O'Shaughnessy W. Proposal of a new method of treating the Blue Epidemic
Cholera by the injection of highly-oxygenised salts into the
venous system. Lancet 1831; 366–71.
4. Малышев В.Д. Кислотно-основное состояние и вводно-электро-
литный баланс в интенсивной терапии. М.: Медицина, 2005.
5. Lang W, Zander R. Prediction of dilutional acidosis based on the
revised classical dilution concept for bicarbonate. J Appl Physiol 2005;
98: 62–71.
6. Ringer S. Concerning the influence exerted by each of the constituents
of the blood on the contraction of the ventricle. J Physiol 1883–1884; 4:
29–42, 222–5.
7. Burgess MJ. Relation of ventricular repolarization to electrocardiographic
T-wave form and arrhythmia vulnerability. Am J Physiol 1979;
236: H391–H402.
8. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological
properties in the deep subepicardium of the canine ventricle:
the M cell. Circ Res 1991; 68: 1729–41.
9. Zygmunt AC, Eddlestone GT, Thomas GP et al. Larger late sodium
conductance in M cells contributes to electrical heterogeneity in canine
ventricle. Am J Physiol Heart Circ Physiol 2001; 281: H689–97.
10. Viswanathan PC, Rudy Y. Cellular arrhythmogenic effects of congenital
and acquired long-QT syndrome in the heterogeneous myocardium.
Circulation 2000; 101: 1192–8.
11. Surawicz B. Contributions of cellular electrophysiology to the understanding
of the electrocardiogram. Experientia 1987; 43: 1061–8.
12. Sodi-Pallares D, Testelli MR, Fishleder B. Effect of an intravenous
infusion of a potassium-insulin glucose solution on the electrocardiographic
signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 1962; 9: 166–81.
13. Selye H: Experimental Cardiovascular Diseases. Springer Verlag,
1970.
14. Opie L. The glucose hypothesis: relation to acute myocardial
ischemia. J Mol Cell Cardiol 1970; 1: 107–14.
15. G.Van den Berghe. How does blood glucose control with insulin save
lives in intensive care? J Clin Invest 2004; 114: 1187–95.
16. Garber AJ et al. American College of Endocrinology Task Force on
Inpatient Diabetes Metabolic Control. American College of endocrinology
position statement on inpatient diabetes and metabolic control.
Endocr Pract 2004; 10: 77–82.
17. Antman EM. Magnesium in Acute MI. Circulation 1995; 92:
2367–72.
18. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate
in suspected acute myocardial infarction: results of the second
Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet
1992; 339: 1553–8.
19. ISIS-4 Collaborative Group. ISIS-4: a randomized factorial trial
assessing early oral captopril, oral mononitrate, and intravenous magnesium
sulphate in 58,050 patients with suspected acute myocardial
infarction. Lancet 1995; 345: 669–85.
20. Higgins JP, Spiegelhalter DJ. Being sceptical about meta-analyses: a
Bayesian perspective on magnesium trials in myocardial infarction. Int
J Epidemiol 2002; 31 (1): 96–104.
21. ACC/AHA Task Force on Practice Guidelines (Committee to Revise
the 1999 Guidelines on the Management of Patients With Acute
Myocardial Infarction). J Am Coll Cardiol 2004; 44: 671–719.
22. Zipes DP, Camm AJ, Borggrefe M et al. ACC/AHA/ESC 2006 guidelines
for management of patients with ventricular arrhythmias and the
prevention of sudden cardiac death: a report of the American College of
Cardiology/American Heart Association Task Force and the European
Society of Cardiology Committee for Practice Guidelines (Writing Committee
to Develop Guidelines for Management of Patients With Ventricular
Arrhythmias and the Prevention of Sudden Cardiac Death). J Am
Coll Cardiol 2006; 48: e247–e346.
23. Elin RJ. Assessment of magnesium status. Clin Chem 1987; 33:
1965–70.
24. Grubbs, RD, and Maguire ME. Magnesium as a regulatory cation:
criteria and evaluation. Magnesium 1987; 6: 113–27.
25. Romani A, Scarpa A. Regulation of cell magnesium. Arch Biochem
Biophys 1992; 298: 1–12.
26. Murphy E, Steenbergen C, Levy LA et al. Cytosolic free magnesium
levels in ischemic rat heart. J Biol Chem 1989; 264: 5622–7.
27. Taber EB, Tan L, Chao CR et al. Pharmacokinetics of ionized versus
total magnesium in subjects with preterm labor and preeclampsia. Am J
Obstet Gynecol 2002; 186 (5): 1017–21.
28. AGUS ZS. Hypomagnesemia. J Am Soc Nephrol 1999; 10: 1616–22.
29. Garfinkel L, Garfinkel D. Magnesium regulation of the glycolytic
pathway and the enzymes involved Magnesium 1985; 4: 60–72.
30. Wacker WE, Parisi AF. Magnesium metabolism. N Engl J Med 1968;
45: 658–63, 712–7, 772–6.
31. Dreizen P, Richards DH. Studies on the role of light and heavy chains
in myosin adenosine triphosphatase. Cold Spring Harbor Symp Quant
Biol 1973; 37: 29–45.
32. Maguire ME. Hormone-sensitive magnesium transport and magnesium
regulation of adenylate cyclase. Trends Pharmacol Sci 1984; 5:
73–7.
33. Dorup I, Clausen T. Correlation between magnesium and potassium
contents in muscle: Role of Na(+)-K+ pump. Am J Physiol 1993; 264:
C457–63.
34. Horie M, Irisawa H, Noma A. Voltage-dependent magnesium block of
adenosine-triphosphate-sensitive potassium channels in guinea-pig
ventricular cells. J Physiol (Lond) 1987; 387: 251–72.
35. White RE, Hartzell HC. Effects of intracellular free magnesium on
calcium current isolated mammalian cardiac muscle. Science 1988;
239: 788–90.
36. O'Rourke B, Backx PH, Marbаn E. Phosphorylation-independent
modulation of L-type calcium channels by magnesium-nucleotide complexes.
Science 1992; 257: 245–8.
37. Iseri LT, French JH. Magnesium: Nature's physiologic calcium blocker.
Am Heart J 1984; 108: 188–93.
38. Tzivoni D, Banai S, Schuger C et al. Treatment of torsade de pointes
with magnesium sulphate. Circulation 1988; 77: 392–7.
39. Уранов В.Н., Попов В.В., Коняхин А.Ю. Под редакцией А.Э.Радзе-
вича. Синдром удлинённого интервала Q–T и внезапная сердеч-
ная смерть. М., 2007.
40. Bonatti V, Rolli A, Botti G. Recording of monophasic action potentials
of the right ventricle in long QT syndromes complicated by severe ventricular
arrhythmias. Eur Heart J 1983; 4: 168–72.
41. Cheng H, Lederer WJ, Cannell MB. Calcium sparks: elementary
events underlying excitation-contraction coupling in heart muscle. Science
1993; 262: 740–4.
42. Murphy E, Freudenrich CC, Levy LA et al. Monitoring cytosolic free
magnesium in cultured chicken heart cells by the use of the fluorescent
indicator furaptra. Proc Natl Acad Sci U S A 1989; 86: 2981–4.
43. Murphy E, Freudenrich CC, Levy LA et al. Monitoring cytosolic free
magnesium in cultured chicken heart cells by the use of the fluorescent
indicator furaptra. Proc Natl Acad Sci U S A 1989; 86: 2981–4.
44. Murphy E, Freudenrich CC, Lieberman M. Cellular magnesium and
Na/Mg exchange in heart cells. Annu Rev Physiol 1991; 53: 273–87.
45. Jennings RB. Early phase of myocardial ischemic injury and infarction.
Am J Cardiol 1969; 24: 753–65.
46. Raab W. Myocardial electrolyte derangement: Crucial feature of
pluricausal, so-called coronary, heart disease. Ann NY Acad Sci 1969;
127: 627–86.
47. Keenan D, Romani A, Scarpa A. Differential regulation of circulating
Mg2+ in the rat by β1- and β2-adrenergic receptor stimulation. Circ Res
1995; 77: 973–83.
48. Meister A. Glutathione Metabolism and Its Selective Modification. J
Biol Chem 1988; 263 (33): 17205–8.